Pre-exposure prophylaxis among men who have sex with men in Côte d'Ivoire: a quantitative study of acceptability.


Journal

AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 1 7 2020
medline: 4 9 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

This cross sectional study was conducted in 2018 in Côte d'Ivoire to assess PrEP acceptability among men who have sex with men (MSM). Two hundred and one men were asked on their intention to use PrEP if made available. Logistic regression accounting for the sampling design was used to analyze associations between high PrEP acceptability and different independent variables including barriers and facilitators. Participants were mostly young (mean age = 25 years), educated (82% with secondary/postsecondary education) and single (95.5%). On average, 3.4 episodes of anal sex were reported monthly and 37.8% of men did not use a condom at last sex. Most MSM (72.6%) had heard of PrEP before enrollment. Overall, 35.3% reported that they would use PrEP very probably if made available. In multivariate analysis, factors associated with high PrEP acceptability were condom use at last sexual intercourse (Odds ratio (OR) = 2.51; 95%Confidence interval (95%CI) = 1.45-4.33); insertive sex as compared to versatile sex (OR = 2.56; 95%CI = 1.14-5.67); free PrEP delivery (OR = 2.45; 95%CI = 1.07-5.59), concerns about side effects (OR = 0.66; 95%CI = 0.48-0.90), and being preoccupied by the fact that post-PrEP antiretroviral therapy could be inefficient (OR = 0.25; 95%CI = 0.14-0.44). PrEP implementation among MSM in Côte d'Ivoire should be accompanied by awareness raising campaigns explaining its utility.

Identifiants

pubmed: 32603610
doi: 10.1080/09540121.2020.1785997
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1228-1236

Subventions

Organisme : CIHR
ID : FDN-143218
Pays : Canada

Auteurs

S Diabaté (S)

Département de médecine sociale et préventive, Université Laval, Québec, Canada.
Centre de recherche du CHU de Québec, Université Laval, Québec, Canada.
Université Alassane Ouattara, Bouaké, Côte d'Ivoire.

O Kra (O)

Université Alassane Ouattara, Bouaké, Côte d'Ivoire.

Y J Biékoua (YJ)

Renaissance Santé Bouaké, Bouaké, Côte d'Ivoire.

S J Pelletier (SJ)

Centre de recherche du CHU de Québec, Université Laval, Québec, Canada.

D G Osso (DG)

Renaissance Santé Bouaké, Bouaké, Côte d'Ivoire.

B Diané (B)

Université Alassane Ouattara, Bouaké, Côte d'Ivoire.

M N'Dhatz-Ebagnitchié (M)

Université Alassane Ouattara, Bouaké, Côte d'Ivoire.

C Ahouada (C)

Hôpital Zone Allada, Allada, Benin.

A K Kobena (AK)

Renaissance Santé Bouaké, Bouaké, Côte d'Ivoire.

M Alary (M)

Département de médecine sociale et préventive, Université Laval, Québec, Canada.
Centre de recherche du CHU de Québec, Université Laval, Québec, Canada.
Institut national de santé publique du Québec, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH